Zum Inhalt springen
· Biorevitalisation
SKU 10910

Monalisa PN

In stock
Volume
1 x 1 mL
Laboratory
GENOSS Co., Ltd.
Origin
Südkorea
Indication
Facial lipoatrophy, soft-tissue augmentation, facial tissue restoration
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Monalisa PN is a polynucleotide dermal filler by Monalisa, formulated for soft tissue augmentation and restoration of facial lipoatrophy. The product contains stabilized polynucleotides at 20 mg/mL with 0.3% lidocaine and is intended for professional use only.

Key Benefits of Monalisa PN

  • Supports soft-tissue augmentation
  • Helps restore facial lipoatrophy
  • Contains stabilized polynucleotides (PN) for tissue support
  • Includes 0.3% lidocaine to improve injection comfort
  • For professional intradermal injection
Key Information
Brand Monalisa
Manufacturer GENOSS Co., Ltd.
Country of Origin South Korea
Ingredients Stabilized polynucleotide gel 20 mg/mL; Lidocaine 0.3%; phosphate-buffered saline
Packaging 1 prefilled glass syringe × 1 mL, Luer-lock, single use; disposable sterile needles provided
Use Type Professional / clinic use only - single-use intradermal injectable
Injection Depth Intradermal (into the dermis / lower dermis)
Protocol / Duration Resorbable; duration is individual and depends on patient factors

Indications and Professional Use

Main indications

  • Facial lipoatrophy
  • Soft tissue augmentation
  • Facial tissue restoration
  • Intradermal aesthetic correction

Professional use

Professional use: For use by licensed medical professionals only, following clinical assessment. Intended for intradermal injection only. Contraindications: Known hypersensitivity to sodium polynucleotide, lidocaine, or other amide-type anaesthetics. Allergic, autoimmune or sarcoid granulomatous disease, or endocarditis. Bleeding disorders, or use of thrombolytic agents, aggregation inhibitors, NSAIDs, anticoagulants or immunosuppressants. Pregnancy or breastfeeding. Patients under 18. Professional-use restrictions: Do not inject into blood vessels. Do not inject where another manufacturer's product is present, or where a non-biodegradable implant is already present.

Treatment areas

  • Face
  • Facial lipoatrophy-affected areas
  • Soft tissue restoration areas

Patient profile

Suitable for adult patients (18+) presenting with facial lipoatrophy or soft tissue volume loss appropriate for intradermal polynucleotide correction, as determined by the treating practitioner. Not suitable for pregnant or breastfeeding patients, or those meeting any contraindication above.

How Monalisa PN Works

Monalisa PN works through stabilized polynucleotides (20 mg/mL) that support soft-tissue augmentation and restoration in areas affected by facial lipoatrophy, with 0.3% lidocaine for injection comfort. It is intended for intradermal aesthetic correction and facial tissue restoration in patients over 18.

Why Order From Allpara

Allpara offers genuine, verified MONALISA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

What is Monalisa PN?

Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.

Is Monalisa PN biodegradable?

Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.

/ Specifications

The datasheet

Brand
MONALISA
Laboratory
GENOSS Co., Ltd.
SKU
10910
Format
1 x 1 mL
Origin
Südkorea
Indication
Facial lipoatrophy, soft-tissue augmentation, facial tissue restoration
Use
Injectable polynucleotide dermal filler with lidocaine (professional use)
/ Product details

The full file

Monalisa PN is a polynucleotide dermal filler by Monalisa, formulated for soft tissue augmentation and restoration of facial lipoatrophy. The product contains stabilized polynucleotides at 20 mg/mL with 0.3% lidocaine and is intended for professional use only.

GENOSS Co., Ltd., country of origin Südkorea.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

What is Monalisa PN?

Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.

Is Monalisa PN biodegradable?

Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.

/ Quick answers

Everything a buyer asks first

What is Monalisa PN?
Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.
Is Monalisa PN biodegradable?
Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.
/ FAQ

Frequently asked

Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.
Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.

More from GENOSS

View laboratory

Clinic alternatives

All products

Monalisa PN

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Monalisa PN is a polynucleotide dermal filler by Monalisa, formulated for soft tissue augmentation and restoration of facial lipoatrophy. The product contains stabilized polynucleotides at 20 mg/mL with 0.3% lidocaine and is intended for professional use only.

Key Benefits of Monalisa PN

  • Supports soft-tissue augmentation
  • Helps restore facial lipoatrophy
  • Contains stabilized polynucleotides (PN) for tissue support
  • Includes 0.3% lidocaine to improve injection comfort
  • For professional intradermal injection
Key Information
Brand Monalisa
Manufacturer GENOSS Co., Ltd.
Country of Origin South Korea
Ingredients Stabilized polynucleotide gel 20 mg/mL; Lidocaine 0.3%; phosphate-buffered saline
Packaging 1 prefilled glass syringe × 1 mL, Luer-lock, single use; disposable sterile needles provided
Use Type Professional / clinic use only - single-use intradermal injectable
Injection Depth Intradermal (into the dermis / lower dermis)
Protocol / Duration Resorbable; duration is individual and depends on patient factors

Indications and Professional Use

Main indications

  • Facial lipoatrophy
  • Soft tissue augmentation
  • Facial tissue restoration
  • Intradermal aesthetic correction

Professional use

Professional use: For use by licensed medical professionals only, following clinical assessment. Intended for intradermal injection only. Contraindications: Known hypersensitivity to sodium polynucleotide, lidocaine, or other amide-type anaesthetics. Allergic, autoimmune or sarcoid granulomatous disease, or endocarditis. Bleeding disorders, or use of thrombolytic agents, aggregation inhibitors, NSAIDs, anticoagulants or immunosuppressants. Pregnancy or breastfeeding. Patients under 18. Professional-use restrictions: Do not inject into blood vessels. Do not inject where another manufacturer's product is present, or where a non-biodegradable implant is already present.

Treatment areas

  • Face
  • Facial lipoatrophy-affected areas
  • Soft tissue restoration areas

Patient profile

Suitable for adult patients (18+) presenting with facial lipoatrophy or soft tissue volume loss appropriate for intradermal polynucleotide correction, as determined by the treating practitioner. Not suitable for pregnant or breastfeeding patients, or those meeting any contraindication above.

How Monalisa PN Works

Monalisa PN works through stabilized polynucleotides (20 mg/mL) that support soft-tissue augmentation and restoration in areas affected by facial lipoatrophy, with 0.3% lidocaine for injection comfort. It is intended for intradermal aesthetic correction and facial tissue restoration in patients over 18.

Why Order From Allpara

Allpara offers genuine, verified MONALISA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

What is Monalisa PN?

Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.

Is Monalisa PN biodegradable?

Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.

More from GENOSS

View laboratory →

Monalisa PN is a polynucleotide dermal filler by Monalisa, formulated for soft tissue augmentation and restoration of facial lipoatrophy. The product contains stabilized polynucleotides at 20 mg/mL with 0.3% lidocaine and is intended for professional use only.

GENOSS Co., Ltd., country of origin Südkorea.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

What is Monalisa PN?

Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.

Is Monalisa PN biodegradable?

Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.